Abstract
C11H11DyN4O11, monoclinic, P21/c (no. 14), a = 12.073(4) Å, b = 14.704(4) Å, c = 8.763(3) Å, β = 94.233(5)°, V = 1551.3(8) Å3, Z = 4, Rgt(F) = 0.0201, wRref(F2) = 0.0555, T = 293 K.
The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
Data collection and handling.
Crystal: | Colourless block |
Size: | 0.18 × 0.18 × 0.12 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 48.9 cm−1 |
Diffractometer, scan mode: | Bruker P4, ω scans |
2θmax, completeness: | 54°, >99% |
N(hkl)measured, N(hkl)unique, Rint: | 9235, 3379, 0.018 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 2994 |
N(param)refined: | 244 |
Programs: | Bruker programs [1], SHELX [2] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
Dy1 | 0.827724(10) | 0.622154(7) | 0.153115(12) | 0.01925(6) |
O1 | 1.03690(16) | 0.30317(13) | −0.3104(2) | 0.0297(4) |
O2 | 1.07952(17) | 0.19565(14) | −0.4752(2) | 0.0348(5) |
O3 | 0.78840(16) | 0.49057(12) | −0.0147(2) | 0.0259(4) |
O4 | 0.71253(19) | 0.62053(11) | −0.0928(2) | 0.0271(4) |
O5 | 1.0187(3) | 0.4143(2) | 0.3482(3) | 0.0701(9) |
O6 | 0.86727(19) | 0.49409(15) | 0.3255(2) | 0.0385(5) |
O7 | 0.99773(19) | 0.52234(14) | 0.1794(2) | 0.0386(5) |
O8 | 0.64434(17) | 0.56117(13) | 0.2082(2) | 0.0293(4) |
O9 | 0.56479(18) | 0.57656(16) | 0.4217(2) | 0.0405(5) |
O10 | 0.7271(2) | 0.63656(14) | 0.3932(2) | 0.0333(5) |
N1 | 0.7357(2) | 0.40731(15) | −0.2986(2) | 0.0240(5) |
N2 | 0.81350(19) | 0.28621(15) | −0.3867(3) | 0.0254(5) |
N3 | 0.9632(2) | 0.47502(17) | 0.2852(3) | 0.0355(6) |
N4 | 0.6424(2) | 0.59069(17) | 0.3431(3) | 0.0268(5) |
C1 | 0.8143(2) | 0.37567(17) | −0.3810(3) | 0.0248(6) |
H1A | 0.8641 | 0.4121 | −0.4293 | 0.030* |
C2 | 0.6788(2) | 0.33277(17) | −0.2420(3) | 0.0223(5) |
C3 | 0.5908(2) | 0.3274(2) | −0.1509(3) | 0.0314(6) |
H3A | 0.5585 | 0.3793 | −0.1127 | 0.038* |
C4 | 0.5530(3) | 0.2416(2) | −0.1193(4) | 0.0391(7) |
H4A | 0.4939 | 0.2352 | −0.0578 | 0.047* |
C5 | 0.6016(3) | 0.1640(2) | −0.1776(4) | 0.0383(7) |
H5A | 0.5735 | 0.1072 | −0.1539 | 0.046* |
C6 | 0.6898(2) | 0.16848(18) | −0.2689(3) | 0.0299(6) |
H6A | 0.7213 | 0.1165 | −0.3079 | 0.036* |
C7 | 0.7289(2) | 0.25542(17) | −0.2995(3) | 0.0228(5) |
C8 | 0.8921(2) | 0.2306(2) | −0.4662(3) | 0.0312(6) |
H8A | 0.8831 | 0.2443 | −0.5747 | 0.037* |
H8B | 0.8736 | 0.1670 | −0.4534 | 0.037* |
C9 | 1.0131(2) | 0.24475(17) | −0.4109(3) | 0.0225(5) |
C10 | 0.7089(3) | 0.50271(17) | −0.2752(3) | 0.0305(7) |
H10A | 0.6298 | 0.5110 | −0.2989 | 0.037* |
H10B | 0.7471 | 0.5390 | −0.3473 | 0.037* |
C11 | 0.7386(2) | 0.53891(17) | −0.1157(3) | 0.0227(5) |
O1W | 0.73540(18) | 0.76199(12) | 0.1590(2) | 0.0304(4) |
H1WB | 0.7278 | 0.7950 | 0.0777 | 0.037* |
H1WA | 0.7348 | 0.7964 | 0.2410 | 0.037* |
Source of material
1-(Carboxymethyl)-1H-benzimidazol-3-ium-3-acetate was prepared according to the reported procedures [3]. Sodium carbonate (0.25 mmol) was added to 1-(carboxymethyl)-1H-benzimidazol-3-ium-3-acetate (0.5 mmol) in distilled water (5 mL) while stirring at room temperature. Once the solution became clear, dysprosium nitrate (0.25 mmol) dissolved in distilled water (5 mL) was added dropwise. After continuous stirring for 15 min, the resulting solution was filtered and placed undisturbed for 2 weeks. Colourless crystals suitable for crystal structure analysis were obtained.
Experimental details
Hydrogen atoms bound to carbon were placed in geometrically idealized positions and refined isotropic using riding model with Uiso(H) = 1.2Ueq(C). The hydrogens bound to coordinated water molecules were located in difference Fourier map and refined with Uiso(H) = 1.2Ueq(O).
Comment
In the recent years, the benzimidazole derivatives and their metal complexes have attracted much attention because of the specific topological frameworks and intresting properties of materials [4], [5], [6], [7]. Furthermore, benzimidazole carboxylic acids and their derivatives are widely used due to their biological activites such as antifilarial, antineoplastic, anthelmintic and antiviral activities [8], [9], [10], [11]. Up to now, several complexes have been built by benzimidazole carboxylic acid [12], [13], [14], [15], [16], [17]. To extend this work, a crystal structure of a related samarium complex was reported by us [18].
The asymmetric unit of the title structures consists of one Dy3+ cation, one 1-(carboxymethyl)-1,3-benzimidazol-3-ium-3-acetate ligand, two nitrate ions and one water molecule. The Dy atom is nine-coordinated showing a distorted, tricapped trigonal prism. The coordination sphere is composed of nine oxygen atoms from a chelating carboxylate group, two monodentate coordinating carboxylate groups, two chelating nitrato ligands, and one coordinated water molecule. The sets of atoms O1w, O8, O10 and O2i (i = x + 2, y + 1/2, −z − 1/2), O3, O7 define the triangular base and upperface, respectively, and O1ii (ii = −x + 2, −y + 1, −z), O4, O6 achieve the cappings of the polyhedron. The Dy—O bond lengths range from 2.3333(19) Å to 2.2608(18) Å. Meanwhile, the two carboxylate groups of one ligand take a μ3-coordination mode bridging three Dy3+ ions to form a two dimensional undulating sheet structure.
Furthermore, there are neither obvious π–π stacking interactions, nor hydrogen bonds existing between the adjacent sheets. Therefore, the packing seems to be dominated by van der Waals forces. To simplify the structure of the two dimensional framework, the Dy atom and the ligand both can be viewed as 3-connected node, therefore the topology of the resulting structure may be described as fes topology with a point symbol of (4.82) [19].
Acknowledgement
This work was supported by the Doctor Foundation of Henan institue of Engineering (No. D2012030).
References
1 Bruker. XSCANS. Bruker AXS Inc., Madison, Wisconsin, USA (2004).Suche in Google Scholar
2 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar
3 Chen, D. B.; Huang, L.: 1-(Carboxymethyl)-1,3-benzimidazol-3- ium-3-acetate. Acta Crystallogr. E62 (2006) o4686–o4688.10.1107/S1600536806038335Suche in Google Scholar
4 Wen, Q. Y.; Chen, J. Q.; Fang, H. C.; Chen, Li; Zhou, Z. Y.; Hu, Z. J.; Cai, Y. P.: Construction of ZnII-based rac-helical chains containing semi-rigid dipolar ligand 1,4-bis(benzimidazol-1-ylmethyl) benzene. Z. Anorg. Allg. Chem. 635 (2009) 567–571.10.1002/zaac.200801233Suche in Google Scholar
5 Lu, H. J.; Fan, Y. T.; Gao, J.; Wang, Q.: 1,4-Bis(1-benzimidazolylmethyl)benzene with Cd(II) and Zn(II) cations: Synthesis and crystal structures of a 2-D coordination polymer and a 3-D supramolecular. Synth. React. Inorg. M. 35 (2005) 305–309.10.1081/SIM-200055247Suche in Google Scholar
6 Liu, X. C.; Guo, X. L.; Niu, Y. Y.; Wang, Q. L.; Cui, Q.; Hou, H. W.; Lv, X. R.; Ng, S. K.: Synthesis and structure of a CdI2 coordination polymer with 1,4-bis(benzimidazole-1-yl-methylene)benzene (bbmb). J. Chem. Crystallogr. 39 (2009) 147–150.10.1007/s10870-008-9445-4Suche in Google Scholar
7 Su, C. Y.; Cai, Y. P.; Chen, C. L.; Smith, M. D.; Kaim, W.; zur Loye H. C.: Ligand-directed molecular architectures: Self-assembly of two-dimensional rectangular metallacycles and three-dimensional trigonal or tetragonal prisms. J. Am. Chem. Soc. 125 (2003) 8595–8613.10.1021/ja034267kSuche in Google Scholar
8 Dubey, R.; Abuzar, S.; Sharma, S.; Chatterjee, R. K.; Katiyar, J. C.: Synthesis and anthelmintic activity of 5(6)-(benzimidazol-2-ylcarbamoyl) and (4-substituted piperazin-1-yl)benzimidazoles. J. Med. Chem. 28 (1985) 1748–1750.10.1002/chin.198609187Suche in Google Scholar
9 Garuti, L.; Roberti, M.; Gentilomi, G.: Synthesis and antiviral assays of some 2-substituted benzimidazole-N-carbamates. Farmaco 55 (2000) 35–39.10.1016/S0014-827X(99)00117-2Suche in Google Scholar
10 Poeta, M. D.; Schell, W. A.; Dykstra, C. C.; Jones, S.; Tidwell, R. R.; Czarny, A.; Bajic, M.; Kumar, A.; Boykin, D.; Perfect, J. R.: Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents. Antimicro. Agents Chemother. 42 (1998) 2495–2502.10.1128/AAC.42.10.2495Suche in Google Scholar PubMed PubMed Central
11 Fei, Z.; Geldbach, T. J.; Zhao, D.; Scopelliti, R.; Dyson, P. J.: Anearly planar water sheet sandwiched between strontium-imidazolium carboxylate coordination polymers. Inorg. Chem. 44 (2005) 5200–5202.10.1021/ic0504238Suche in Google Scholar PubMed
12 Fei, Z.; Zhao, D.; Geldbach, T. J.; Scopelliti, R.; Dyson, P. J.; Antonijevic, S.: Asynthetic zwitterionic water channel: characterisation in the solid state by X-ray crystallography and NMR spectroscopy. Angew. Chem. Int. Ed. 44 (2005) 5720-5725.10.1002/anie.200500207Suche in Google Scholar PubMed
13 Huang, L.; Chen, D. B.: Tetraaquabis(1,3-benzimidazol-3-ium-1,3-diacetato)cobalt(II) hemihydrate. Acta Crystallogr. E62 (2006) m3532–m3534.10.1107/S1600536806049920Suche in Google Scholar
14 Huang, L.; Chen, D. B.: Tetraaquabis[1-(carboxylatomethyl)-1,3-benzimidazol-3-ium-3-acetato-κO]manganese(II)dihydrate. Acta Crystallogr. E62 (2006) m2872–m2874.10.1107/S1600536806040645Suche in Google Scholar
15 Huang, L.; Chen, D. B.: Crystal structure of hexaaquanickel(II) bis[1-(carboxylatomethyl)-1,3- benzimidazol-3-ium-3-acetato] dihydrate. Z. Kristallogr. − NCS 223 (2008) 163–164.Suche in Google Scholar
16 Wang, B. L.; Li, J. P.; Li, G.; Zhu, L.; Bao, G. L.: Synthesis, crystal structures and properties of Zn(II) and Cd(II) complexes constructed from benzimidazolyl carboxylic acid. Synth. React. Inorg. M. 38 (2008) 750–757.10.1080/15533170802525837Suche in Google Scholar
17 Huang, L.; Zhong, A. G.; Chen, D.B.; Qiu, D.; Liang, H. D.: Synthesis, structure, spectroscopic properties, and theoretical studies of alkaline earth metal complexes of 1,3-bis(carboxymethyl) benzimidazolium. J. Mol. Struct. 984 (2010) 39–50.10.1016/j.molstruc.2010.09.005Suche in Google Scholar
18 Zhang, Q.; He, Li.; Yu, Q. Y.: Crystal structure of poly[aqua-bis(nitrato-κ2O,O′)-(μ3-1,3-benzimidazol-3-ium-1,3-diacetato-κ4O,O′:O′′:O′′′)samarium(III)], C11H11N4O11Sm. Z. Kristallogr. − NCS 230 (2015) 107–108.10.1515/ncrs-2014-0255Suche in Google Scholar
19 Blatov, V. A.: Nanocluster analysis of intermetallic structures with the program package TOPOS. Struct. Chem. 23 (2012) 955–963.10.1007/s11224-012-0013-3Suche in Google Scholar
©2017 Qian Zhang et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Artikel in diesem Heft
- Cover and Frontmatter
- Crystal structure of poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)manganese(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2) C42H40Cl2MnN6O10S2
- The crystal structure of 1,2-bis[2-methyl-5-(3-cyanophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluoro-cyclopent-1-ene, C29H16F6N2S2
- Crystal structure of the first characterized polymeric copper and sodium complex diaqua-(tris-acetato-κO,O′)(μ2-acetato-κO′′)dinatrium copper(II) monohydrate, C8H18CuNa2O11
- The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-3-yl-methylene)aniline, C18H22N2
- Crystal structure of methyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22N2O5
- Crystal structure of bis(1,3-bis(diphenylphosphino)propane-κ2P,P′)silver(I) trifluorosulfonate–methanol (1:0.5), [Ag(C27H26P2)]SO3CF3⋅0.5CH3OH
- Crystal structure of μ-1,4-bis(diphenylphosphine)butane-2,9-dimethyl-1,10-phenanthroline-κ2N:N′-bis(cyano-κC)dicopper(I)]-water, C58H56Cu2N6O2P2
- Crystal structure of N2,N6-bis(1-hydrazinyl-2-methyl-1-oxopropan-2-yl) pyridine-2,6-dicarboxamide, C15H23N7O4
- Crystal structure of 1,3-dimethyl-2-phenyl-1H-perimidin-3-ium iodide, C19H17IN2
- Crystal structure of diaqua-(2,2′-(butane-1,4-diyl)-bis(5-carboxy-1H-imidazole-4-carboxylato)-κ4O,O′,N,N′)cadmium(II) monohydrate, C14H18O11N4Cd
- Crystal structure of ethyl (E)-3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl) acrylate, C15H14Cl2FNO3
- Crystal structure of bis-(1-(4-chlorophenyl)-3-phenyl-4-thenoyl-1H-pyrazol-5-ol-κ2O,O′)-(N,N-dimethylformamide)zinc(II), C43H31Cl2N5O5S2Zn
- Crystal structure of tetrakis(μ3-2-(N-(2-hydroxyethyl)amino)ethoxo)-tetrachloro-tetra-cobalt(II) methanol solvate, C17H44Cl4Co4N4O9
- Crystal structure of 3-amino-1-(4-bromophenyl)-9-methoxy-1H-benzo[f]chromene-2-carbonitrile, C21H15BrN2O2
- Crystal structure of 2-amino-4-(4-isopropyl-phenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2-c]chromene, C22H18N2O3
- Crystal structure of 3-amino-8-methoxy-1-(4-methoxy phenyl)-1H-benzo[f]chromene-2-carbonitrile, C22H18N2O3
- Crystal structure of monoaqua-[6,6′-((1E,1′E)-(1,2-phenylene bis(azanylylidene))bis(methanylylidene))bis(4-bromo-2-nitrophenolato-κ4N,N′,O,O′)]zinc(II), C20H12Br2N4O7Zn
- Crystal structure of 11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one – acetonitril (1/2), C33H41N3O2
- Crystal structure of tert-butyl (phenylsulfinyl)carbamate, C11H15NO3S
- Crystal structure of catena-poly{diaqua-bis(3-(1H-1,2,4-triazol-1-yl)benzoato-κ2O:N)copper(II)} monohydrate, C18H18CuN6O7
- Crystal structure of tetraaqua-bis(3-(4H-1,2,4-triazol-4-yl)benzoato-κN)cobalt(II), C18H20CoN6O8
- The crystal structure of 4-bromo-N-cyclopropyl-2,5-difluorobenzenesulfonamide, C9H8BrF2NO2S
- Crystal structure of ([3,3′-bipyridine]-6,6′-dicarboxylato-κ2O:O′)-bis(1,2-bis(4-pyridyl)ethane-κ2N:N′)disilver(I) dihydrate, C37H35Ag2N5O6
- The crystal structure of (4-(1H-1,2,4-triazol-1-yl)benzoato-κN)-[4-(1H-1,2,4-triazol-1-yl)benzoic acid-κN]silver(I), C18H13AgN6O4
- Crystal structure of 3-(4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, C17H16O2
- Crystal structure of bis(2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)-5-methoxyphenolato-κ2O,N)copper(II), C36H38CuN4O6
- Crystal structure of poly[1,2-bis(1,2,4-triazol-4-yl)ethane-κ2N:N′]silver(I) bromate monohydrate]silver(I), C6H10AgBrN6O4
- The crystal structure of 2,3,5-triphenyl-2,3-dihydro-1H-tetrazol-1-ium 2,3-dioxoindoline-5-sulfonate, C27H19N5O5S
- Crystal structure of 3-(2-amino-1,3-selenazol-4-yl)-2H-chromen-2-one – dimethylformamide (1/1), C15H15N3O3Se
- Crystal structure of diethyl 3,3′-(diazene-1,2-diyl)(E)-dibenzoate, C18H18N2O4
- Crystal structure of cis-bis((1H-benzimidazol-2-yl)methanol-κN,O)-bis(isothiocyanato-κN)nickel(II), C18H16N6NiO2S2
- Crystal structure of bis(2-(2′-hydroxy-5′-methoxyphenyl)-1H-benzimidazole)boron – tetrahydrofuran (1/1), C36H37N4O6B
- Crystal structure of poly[aqua-bis(nitrato-κ2O,O′)-(μ3-1,3-benzimidazol-3-ium-1,3-diacetato-κ4O,O′:O′′:O′′′)dysprosium(III)], C11H11DyN4O11
- Crystal structure of n-butyl-tris(dicyclo-hexylamido)hafnium(IV), C40H75HfN3
- Crystal structure of (E)-1-[1-(3-chloro-4-fluoro-phenyl)ethylidene]-2-(2,4-dinitrophenyl)hydrazine, C28H20Cl2F2N8O8
- The crystal structure of ethyl 4-((2-hydroxybenzyl)amino)benzoate, a Schiff base, C16H17NO3
- Crystal structure of 3-(2-(4-isobutylphenyl)propanoyl)-1-methylimidazolidine-2,4-dione, C17H22N2O3
- Crystal structure of poly[(μ3-2-(pyrazin-2-ylthio)acetato-κ3N:O:S)silver(I)], C6H5AgN2O2S
- Crystal structure of (E)-1-(3-((E)-((2-hydroxynaphthalen-1-yl)methylene)amino)phenyl)ethanone O-benzyl oxime, C26H22N2O2
- Crystal structure of (E)-2,3-dihydroxybenzaldehyde O-(2-((((E)-1-(2,5-dihydroxyphenyl)ethylidene)amino)oxy)ethyl) oxime monohydrate, C17H20N2O7
- Crystal structure of 4-(chloromethyl)-3-nitrobenzoic acid, C8H6ClNO4
- Crystal stucture of 4-((10H-phenothiazin-10-yl)methyl)-2,6-di-tert-butylphenol, C27H31NOS
- The crystal structure of ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C13H10F3N3O4
- Crystal structure of catena-poly[di-(μ3-oxido-κ3O:O:O)-tetraoxido-(μ2-5′-(pyrazin-2-yl)-1H,2′H-3,3′-bi(1,2,4-triazole)-κ2N:N′)dimolybdenum(VI)], C8H6Mo2N8O6
- Crystal structure of (3,6-dioxocyclohexa-1,4-diene-1,4-bis(olato)-κ4O,O′:O′′,O′′′)-bis(tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′))-dizinc(II) bis(hexafluorophosphate(V)), C42H38F12N8O4P2Zn2
- Crystal structure of catena-poly[hexakis(μ2-2-acetylphenolato-κ3O:O,O′)trimanganese(II)], C48H42Mn3O12
- The crystal structure of 2,2-difluoro-4-(trifluoromethyl)-2,5-dihydro-[1,3,2]dioxaborinino[5,4-c]chromen-3-ium-2-uide, C11H6BF5O3
- Crystal structure of methyl (E)-2-(4-(diethylamino)-2-hydroxybenzylidene)hydrazine-1-carboxylate, C13H19N3O3
- The crystal structure of tert-butyl 2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylate, C10H15N3O2
- Crystal structure of 1,1-bis(η5-adamantylcyclopentadienyl)-3-phenyl-2-trimethylsilyl-2,3-dihydroisotitanazole, C42H55NSiTi
- Crystal structure of 2-(4-(2-(4-benzylpiperazin-1-yl)ethyl)benzyl)isoindoline-1,3-dione, C28H29N3O2
- Important impurity of Flupirtine – a single crystal study on ethyl (6-amino-5-((ethoxycarbonyl)amino)pyridin-2-yl)(4-fluorobenzyl)carbamate, C18H21FN4O4
- Crystal structure of ethyl 3-(4-methoxyphenyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-pyrazole-5-carboxylate, C22H22N2O5
- Crystal structure of 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate methanol solvate, C37H35N1O10
- The crystal structure of the inner salt of 2-[(aminoiminomethyl)amino]ethylcarbamic acid [systematic name: (2-((diaminomethylene)ammonio)ethyl)carbamate], C4H10N4O2
- Crystal structure of (8-hydroxy-5-nitroquinolinium) perchlorate – 8-hydroxy-5-nitroquinoline (1/1), C18H13ClN4O10
- The crystal structure of (5-methyl-1,2,4-oxadiazol-3-yl)ferrocene, C13H12FeN2O
- Crystal structure of methyl 1-(2-(fluorosulfonyl)ethyl)-2-oxocyclopentanecarboxylate, C9H13FO5S
- Crystal structure of the triclinic modification of 1-methyl-4-nitroimidzole, C4H5N3O2
- Corrigendum
- Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O
Artikel in diesem Heft
- Cover and Frontmatter
- Crystal structure of poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)manganese(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2) C42H40Cl2MnN6O10S2
- The crystal structure of 1,2-bis[2-methyl-5-(3-cyanophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluoro-cyclopent-1-ene, C29H16F6N2S2
- Crystal structure of the first characterized polymeric copper and sodium complex diaqua-(tris-acetato-κO,O′)(μ2-acetato-κO′′)dinatrium copper(II) monohydrate, C8H18CuNa2O11
- The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-3-yl-methylene)aniline, C18H22N2
- Crystal structure of methyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22N2O5
- Crystal structure of bis(1,3-bis(diphenylphosphino)propane-κ2P,P′)silver(I) trifluorosulfonate–methanol (1:0.5), [Ag(C27H26P2)]SO3CF3⋅0.5CH3OH
- Crystal structure of μ-1,4-bis(diphenylphosphine)butane-2,9-dimethyl-1,10-phenanthroline-κ2N:N′-bis(cyano-κC)dicopper(I)]-water, C58H56Cu2N6O2P2
- Crystal structure of N2,N6-bis(1-hydrazinyl-2-methyl-1-oxopropan-2-yl) pyridine-2,6-dicarboxamide, C15H23N7O4
- Crystal structure of 1,3-dimethyl-2-phenyl-1H-perimidin-3-ium iodide, C19H17IN2
- Crystal structure of diaqua-(2,2′-(butane-1,4-diyl)-bis(5-carboxy-1H-imidazole-4-carboxylato)-κ4O,O′,N,N′)cadmium(II) monohydrate, C14H18O11N4Cd
- Crystal structure of ethyl (E)-3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl) acrylate, C15H14Cl2FNO3
- Crystal structure of bis-(1-(4-chlorophenyl)-3-phenyl-4-thenoyl-1H-pyrazol-5-ol-κ2O,O′)-(N,N-dimethylformamide)zinc(II), C43H31Cl2N5O5S2Zn
- Crystal structure of tetrakis(μ3-2-(N-(2-hydroxyethyl)amino)ethoxo)-tetrachloro-tetra-cobalt(II) methanol solvate, C17H44Cl4Co4N4O9
- Crystal structure of 3-amino-1-(4-bromophenyl)-9-methoxy-1H-benzo[f]chromene-2-carbonitrile, C21H15BrN2O2
- Crystal structure of 2-amino-4-(4-isopropyl-phenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2-c]chromene, C22H18N2O3
- Crystal structure of 3-amino-8-methoxy-1-(4-methoxy phenyl)-1H-benzo[f]chromene-2-carbonitrile, C22H18N2O3
- Crystal structure of monoaqua-[6,6′-((1E,1′E)-(1,2-phenylene bis(azanylylidene))bis(methanylylidene))bis(4-bromo-2-nitrophenolato-κ4N,N′,O,O′)]zinc(II), C20H12Br2N4O7Zn
- Crystal structure of 11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one – acetonitril (1/2), C33H41N3O2
- Crystal structure of tert-butyl (phenylsulfinyl)carbamate, C11H15NO3S
- Crystal structure of catena-poly{diaqua-bis(3-(1H-1,2,4-triazol-1-yl)benzoato-κ2O:N)copper(II)} monohydrate, C18H18CuN6O7
- Crystal structure of tetraaqua-bis(3-(4H-1,2,4-triazol-4-yl)benzoato-κN)cobalt(II), C18H20CoN6O8
- The crystal structure of 4-bromo-N-cyclopropyl-2,5-difluorobenzenesulfonamide, C9H8BrF2NO2S
- Crystal structure of ([3,3′-bipyridine]-6,6′-dicarboxylato-κ2O:O′)-bis(1,2-bis(4-pyridyl)ethane-κ2N:N′)disilver(I) dihydrate, C37H35Ag2N5O6
- The crystal structure of (4-(1H-1,2,4-triazol-1-yl)benzoato-κN)-[4-(1H-1,2,4-triazol-1-yl)benzoic acid-κN]silver(I), C18H13AgN6O4
- Crystal structure of 3-(4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, C17H16O2
- Crystal structure of bis(2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)-5-methoxyphenolato-κ2O,N)copper(II), C36H38CuN4O6
- Crystal structure of poly[1,2-bis(1,2,4-triazol-4-yl)ethane-κ2N:N′]silver(I) bromate monohydrate]silver(I), C6H10AgBrN6O4
- The crystal structure of 2,3,5-triphenyl-2,3-dihydro-1H-tetrazol-1-ium 2,3-dioxoindoline-5-sulfonate, C27H19N5O5S
- Crystal structure of 3-(2-amino-1,3-selenazol-4-yl)-2H-chromen-2-one – dimethylformamide (1/1), C15H15N3O3Se
- Crystal structure of diethyl 3,3′-(diazene-1,2-diyl)(E)-dibenzoate, C18H18N2O4
- Crystal structure of cis-bis((1H-benzimidazol-2-yl)methanol-κN,O)-bis(isothiocyanato-κN)nickel(II), C18H16N6NiO2S2
- Crystal structure of bis(2-(2′-hydroxy-5′-methoxyphenyl)-1H-benzimidazole)boron – tetrahydrofuran (1/1), C36H37N4O6B
- Crystal structure of poly[aqua-bis(nitrato-κ2O,O′)-(μ3-1,3-benzimidazol-3-ium-1,3-diacetato-κ4O,O′:O′′:O′′′)dysprosium(III)], C11H11DyN4O11
- Crystal structure of n-butyl-tris(dicyclo-hexylamido)hafnium(IV), C40H75HfN3
- Crystal structure of (E)-1-[1-(3-chloro-4-fluoro-phenyl)ethylidene]-2-(2,4-dinitrophenyl)hydrazine, C28H20Cl2F2N8O8
- The crystal structure of ethyl 4-((2-hydroxybenzyl)amino)benzoate, a Schiff base, C16H17NO3
- Crystal structure of 3-(2-(4-isobutylphenyl)propanoyl)-1-methylimidazolidine-2,4-dione, C17H22N2O3
- Crystal structure of poly[(μ3-2-(pyrazin-2-ylthio)acetato-κ3N:O:S)silver(I)], C6H5AgN2O2S
- Crystal structure of (E)-1-(3-((E)-((2-hydroxynaphthalen-1-yl)methylene)amino)phenyl)ethanone O-benzyl oxime, C26H22N2O2
- Crystal structure of (E)-2,3-dihydroxybenzaldehyde O-(2-((((E)-1-(2,5-dihydroxyphenyl)ethylidene)amino)oxy)ethyl) oxime monohydrate, C17H20N2O7
- Crystal structure of 4-(chloromethyl)-3-nitrobenzoic acid, C8H6ClNO4
- Crystal stucture of 4-((10H-phenothiazin-10-yl)methyl)-2,6-di-tert-butylphenol, C27H31NOS
- The crystal structure of ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C13H10F3N3O4
- Crystal structure of catena-poly[di-(μ3-oxido-κ3O:O:O)-tetraoxido-(μ2-5′-(pyrazin-2-yl)-1H,2′H-3,3′-bi(1,2,4-triazole)-κ2N:N′)dimolybdenum(VI)], C8H6Mo2N8O6
- Crystal structure of (3,6-dioxocyclohexa-1,4-diene-1,4-bis(olato)-κ4O,O′:O′′,O′′′)-bis(tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′))-dizinc(II) bis(hexafluorophosphate(V)), C42H38F12N8O4P2Zn2
- Crystal structure of catena-poly[hexakis(μ2-2-acetylphenolato-κ3O:O,O′)trimanganese(II)], C48H42Mn3O12
- The crystal structure of 2,2-difluoro-4-(trifluoromethyl)-2,5-dihydro-[1,3,2]dioxaborinino[5,4-c]chromen-3-ium-2-uide, C11H6BF5O3
- Crystal structure of methyl (E)-2-(4-(diethylamino)-2-hydroxybenzylidene)hydrazine-1-carboxylate, C13H19N3O3
- The crystal structure of tert-butyl 2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylate, C10H15N3O2
- Crystal structure of 1,1-bis(η5-adamantylcyclopentadienyl)-3-phenyl-2-trimethylsilyl-2,3-dihydroisotitanazole, C42H55NSiTi
- Crystal structure of 2-(4-(2-(4-benzylpiperazin-1-yl)ethyl)benzyl)isoindoline-1,3-dione, C28H29N3O2
- Important impurity of Flupirtine – a single crystal study on ethyl (6-amino-5-((ethoxycarbonyl)amino)pyridin-2-yl)(4-fluorobenzyl)carbamate, C18H21FN4O4
- Crystal structure of ethyl 3-(4-methoxyphenyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-pyrazole-5-carboxylate, C22H22N2O5
- Crystal structure of 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate methanol solvate, C37H35N1O10
- The crystal structure of the inner salt of 2-[(aminoiminomethyl)amino]ethylcarbamic acid [systematic name: (2-((diaminomethylene)ammonio)ethyl)carbamate], C4H10N4O2
- Crystal structure of (8-hydroxy-5-nitroquinolinium) perchlorate – 8-hydroxy-5-nitroquinoline (1/1), C18H13ClN4O10
- The crystal structure of (5-methyl-1,2,4-oxadiazol-3-yl)ferrocene, C13H12FeN2O
- Crystal structure of methyl 1-(2-(fluorosulfonyl)ethyl)-2-oxocyclopentanecarboxylate, C9H13FO5S
- Crystal structure of the triclinic modification of 1-methyl-4-nitroimidzole, C4H5N3O2
- Corrigendum
- Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O